AI assistant
Opthea Ltd — Capital/Financing Update 2014
Nov 24, 2014
32698_rns_2014-11-24_b90b5a83-e577-4756-a189-935b6c2c0ed8.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [211 x 55] intentionally omitted <==
25 November 2014
Market Announcements Office ASX Limited MELBOURNE VIC 3000
Dear Sir/Madam
Equity Capital Raising Confirmation of placement of new shares
Following approval by shareholders at the Annual General Meeting on 18 November 2014, the board of directors advises the issue of 73,142,857 fully paid ordinary shares in the capital of the Company together with 40,000,003 options over fully paid ordinary shares to various sophisticated and professional investors.
This placement raised $12.8 million and completes the successful capital raising announced on 6 October 2014.
Yours faithfully
==> picture [131 x 66] intentionally omitted <==
Mike Tonroe Company Secretary Circadian Technologies Limited
Suite 0403 Level 4 650 Chapel Street South Yarra Victoria 3141 Australia T +61 (3) 9826 0399 F +61 (3) 9824 0083 www.circadian.com.au
ABN 32 006 340 567
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement, application for quotation of additional securities and agreement
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13
Name of entity
Circadian Technologies Limited
ABN
32 006 340 567
We (the entity) give ASX the following information.
Part 1 - All issues
You must complete the relevant sections (attach sheets if there is not enough space).
| 1 +Class of+securities issued or to be issued 2 Number of+securities issued or to be issued (if known) or maximum number which may be issued 3 Principal terms of the+securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion) |
Ordinary fully paid shares and quoted options. |
|---|---|
| 113,142,860 quoted ordinary shares and options. |
|
| 1. 73,142,857 ordinary fully paid shares issued under a placement approved by members at the 2014 AGM; and 2. 40,000,003 options to purchase ordinary shares at an exercise price of $0.27 exercisable by 25 November 2018 issued under a placement approved by members at the 2014AGM. |
- See chapter 19 for defined terms.
Appendix 3B Page 1
04/03/2013 ME_116464776_2 (W2007)
| 4 Do the+securities rank equally in all respects from the+issue date with an existing+class of quoted +securities? If the additional+securities do not rank equally, please state: • the date from which they do • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 5 Issue price or consideration 6 Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets) 6a Is the entity an+eligible entity that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b – 6h in relation to the+securities the subject of this Appendix 3B, and comply with section 6i 6b The date the security holder resolution under rule 7.1A was passed 6c Number of+securities issued without security holder approval under rule 7.1 6d Number of+securities issued with security holder approval under rule 7.1A |
Yes, the shares (and the shares issued on exercise of the options) will rank equally in all respects from the issue date. |
|---|---|
| $0.175 per share and nil consideration for the options |
|
| Development of the company’s asset OPT- 302 to the completion of Phase I and IIa clinical trials. (Refer to ASX announcement dated 6 October 2014 for further details). |
|
| Not applicable | |
| Not applicable | |
| Not applicable | |
| Not applicable |
| 6e Number of+securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting) 6f Number of+securities issued under an exception in rule 7.2 6g If+securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation. 6h If+securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements 6i Calculate the entity’s remaining issue capacity under rule 7.1 and rule 7.1A – complete Annexure 1 and release to ASX Market Announcements 7 +Issue dates Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A. Cross reference: item 33 of Appendix 3B. 8 Number and +class of all +securities quoted on ASX (_including_the +securities in section 2 if applicable) |
Not applicable | Not applicable |
|---|---|---|
| Not applicable | ||
Not applicable |
||
| Not applicable | ||
| Not applicable | ||
| 1. 73,142,857 ordinary shares – issue date on 25 November 2014; and 2. 40,000,003 options - issue date on 25 November 2014. |
||
| Number | +Class | |
| 148,086,328 49,726,672 |
Ordinary Quoted options |
- See chapter 19 for defined terms.
Appendix 3B Page 3
04/03/2013 ME_116464776_2 (W2007)
Number +Class 9 Number and +class of all Not applicable Not applicable +securities not quoted on ASX ( including the +securities in section 2 if applicable) 10 Dividend policy (in the case of a The ability of the Company to offer dividends trust, distribution policy) on the (if any) is contingent on it making taxable increased capital (interests) profits. The determination of any dividend payable is at the absolute discretion of the Directors.
Part 2 - Pro rata issue
| 11 Is security holder approval required? 12 Is the issue renounceable or non- renounceable? 13 Ratio in which the+securities will be offered 14 +Class of+securities to which the offer relates 15 +Record date to determine entitlements 16 Will holdings on different registers (or subregisters) be aggregated for calculating entitlements? 17 Policy for deciding entitlements in relation to fractions 18 Names of countries in which the entity has security holders who will not be sent new offer documents Note: Security holders must be told how their entitlements are to be dealt with. Cross reference: rule 7.7. |
Not applicable |
|---|---|
| Not applicable | |
| Not applicable | |
| Not applicable | |
| Not applicable | |
| Not applicable | |
| Not applicable | |
| Not applicable |
| 19 Closing date for receipt of acceptances or renunciations 20 Names of any underwriters 21 Amount of any underwriting fee or commission 22 Names of any brokers to the issue 23 Fee or commission payable to the broker to the issue 24 Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of security holders 25 If the issue is contingent on security holders’ approval, the date of the meeting 26 Date entitlement and acceptance form and offer documents will be sent to persons entitled 27 If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders 28 Date rights trading will begin (if applicable) 29 Date rights trading will end (if applicable) 30 How do security holders sell their entitlements_in full_through a broker? 31 How do security holders sell_part_ of their entitlements through a broker and accept for the balance? |
Not applicable |
|---|---|
| Not applicable | |
| Not applicable | |
| Not Applicable | |
| Not Applicable | |
| Not Applicable | |
| Not applicable | |
| Not applicable | |
| Not Applicable | |
| Not applicable | |
| Not applicable | |
| Not applicable | |
| Not applicable |
- See chapter 19 for defined terms.
Appendix 3B Page 5
04/03/2013 ME_116464776_2 (W2007)
-
32 How do security holders dispose Not applicable of their entitlements (except by sale through a broker)?
-
33 +Issue date Not applicable
Part 3 - Quotation of securities
You need only complete this section if you are applying for quotation of securities
-
34 Type of[+] securities ( tick one )
-
(a) +Securities described in Part 1
-
(b)[All other ][+][securities ]
Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are providing the information or documents
-
35[If the ][+][securities are ][+][equity securities, the names of the 20 largest holders of the ] additional[+] securities, and the number and percentage of additional[+] securities held by those holders
-
36[If the ] +securities setting out the number of holders in the categories[+][securities are ][+][equity securities, a distribution schedule of the additional ] 1 - 1,000
-
1,001 - 5,000
-
5,001 - 10,000 10,001 - 100,000 100,001 and over
-
37 A copy of any trust deed for the additional[+] securities
Entities that have ticked box 34(b)
| 38 Number of+securities for which +quotation is sought 39 +Class of+securities for which quotation is sought 40 Do the+securities rank equally in all respects from the+issue date with an existing+class of quoted +securities? If the additional+securities do not rank equally, please state: • the date from which they do • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 41 Reason for request for quotation now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another+security, clearly identify that other+security) 42 Number and +class of all +securities quoted on ASX (_including_the+securities in clause 38) |
Not applicable | |
|---|---|---|
| Not applicable | ||
| Not applicable | ||
| Not applicable | ||
| Number | +Class | |
| Not applicable | Not applicable |
- See chapter 19 for defined terms.
Appendix 3B Page 7
04/03/2013 ME_116464776_2 (W2007)
Quotation agreement
-
1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.
-
2 We warrant the following to ASX.
-
The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.
-
There is no reason why those[+] securities should not be granted +quotation.
-
An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty
-
Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.
-
If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.
-
3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
-
4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.
25 November 2014 Sign here: ............................................................ Date: ......................... (Company secretary)
Mike Tonroe
Print name: .........................................................
== == == == ==
Appendix 3B – Annexure 1
Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities
Introduced 01/08/12 Amended 04/03/13
Part 1
==> picture [403 x 440] intentionally omitted <==
----- Start of picture text -----
Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated
Insert number of fully paid [+] ordinary
securities on issue 12 months before the
+ issue date or date of agreement to issue
Add the following:
• Number of fully paid [+] ordinary
securities issued in that 12 month
period under an exception in rule 7.2
• Number of fully paid [+] ordinary
securities issued in that 12 month
period with shareholder approval
• Number of partly paid [+] ordinary
securities that became fully paid in that
12 month period
Note:
• Include only ordinary securities here –
other classes of equity securities
cannot be added
• Include here (if applicable) the
securities the subject of the Appendix
3B to which this form is annexed
• It may be useful to set out issues of
securities on different dates as
separate line items
Subtract the number of fully paid
+ ordinary securities cancelled during that
12 month period
“A”
----- End of picture text -----
- See chapter 19 for defined terms.
Appendix 3B Page 9
04/03/2013 ME_116464776_2 (W2007)
| Step 2: Calculate 15% of “A” | |
| “B” | 0.15 [Note: this value cannot be changed] |
| Multiply“A” by 0.15 | |
| Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has already been used |
|
| Insertnumber of+equity securities issued or agreed to be issued in that 12 month period_not counting_those issued: • Under an exception in rule 7.2 • Under rule 7.1A • With security holder approval under rule 7.1 or rule 7.4 Note: • This applies to equity securities, unless specifically excluded – not just ordinary securities • Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed • It may be useful to set out issues of securities on different dates as separate line items |
|
| “C” | |
| Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule 7.1 |
|
| “A” x 0.15 Note: number must be same as shown in Step 2 |
|
| Subtract“C” Note: number must be same as shown in Step 3 |
|
| Total[“A” x 0.15] – “C” | [Note: this is the remaining placement capacity under rule 7.1] |
| “C” | “C” |
|---|---|
| Step 4: Subtract “C” from [“A” x “B”] to calculate remaining | |
| placement capacity under rule 7.1 | |
| “A” x 0.15 | |
| Note: number must be same as shown in | |
| Step 2 | |
| Subtract“C” | |
| Note: number must be same as shown in | |
| Step 3 | |
| Total[“A” x 0.15] – “C” | [Note: this is the remaining placement |
| capacity under rule 7.1] |
Part 2
| art 2 | art 2 |
|---|---|
| Rule 7.1A – Additional placement capacity for eligible entities | |
| Step 1: Calculate “A”, the base figure from which the placement capacity is calculated |
|
| “A” Note: number must be same as shown in Step 1 of Part 1 |
|
| Step 2: Calculate 10% of “A” | |
| “D” | 0.10 Note: this value cannot be changed |
| Multiply“A” by 0.10 | |
| Step 3: Calculate “E”, the amount 7.1A that has already been used |
of placement capacity under rule |
| Insertnumber of+equity securities issued or agreed to be issued in that 12 month period under rule 7.1A Notes: • This applies to equity securities – not just ordinary securities • Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed • Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained • It may be useful to set out issues of securities on different dates as separate line items |
|
| “E” |
- See chapter 19 for defined terms.
Appendix 3B Page 11
04/03/2013 ME_116464776_2 (W2007)
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A
“A” x 0.10 Note: number must be same as shown in Step 2 Subtract “E” Note: number must be same as shown in Step 3 Total [“A” x 0.10] – “E” Note: this is the remaining placement capacity under rule 7.1A
CLASS: FP /ORDINARY FULLY PAID SHARES
HOLDER NO NAME AND ADDRESS UNITS % I/C RANK
ACCBELL NOMINEES PTY LTD 32,415,974 21.89 1
HSBC CUSTODY NOMINEES 18,243,642 12.32 2
(AUSTRALIA) LIMITED-GSCO ECA
BNP PARIBAS NOMS PTY LTD 13,486,971 9.11 3
<DRP>
HSBC CUSTODY NOMINEES 12,627,687 8.53 4
(AUSTRALIA) LIMITED
CITICORP NOMINEES PTY LIMITED 11,979,355 8.09 5
JAGEN PTY LTD 5,714,286 3.86 6
J P MORGAN NOMINEES AUSTRALIA 4,924,479 3.33 7
LIMITED
WARBONT NOMINEES PTY LTD 3,300,000 2.23 8
<ACCUMULATION ENTREPOT A/C>
LUDWIG INSTITUTE FOR CANCER 3,122,090 2.11 9
RESEARCH LTD
UBS NOMINEES PTY LTD 2,500,000 1.69 10
HSBC CUSTODY NOMINEES 2,000,000 1.35 11
(AUSTRALIA) LIMITED - A/C 3
CAPITAL MACQUARIE PTY LIMITED 1,928,304 1.30 12
4 EYES LIMITED 1,643,550 1.11 13
<WORSLEY FAMILY A/C>
DR CHOON-JOO KHO 1,243,286 0.84 14
CHEMICAL TRUSTEE LIMITED 1,158,108 0.78 15
TRADERS MACQUARIE PTY LIMITED 907,161 0.61 16
NATIONAL NOMINEES LIMITED 762,732 0.52 17
JFF STEVEN PTY LTD 714,867 0.48 18
PHILADELPHIA INVESTMENTS 653,859 0.44 19
PTY LTD
PRIMDONN NOMINEES PTY LIMITED 650,000 0.44 20
<PRIMDONN SECURITIES SF AC>
*** REPORT TOTAL *** 119,976,351 81.02
*** REMAINDER *** 28,109,977 18.98
-----------------------
*** GRAND TOTAL *** 148,086,328 100.00
=======================
1 1001 5001 10001 100001 * TOTAL *
to to to to to
1000 5000 10000 100000 (MAX)
FP /ORDINARY FULLY PAID SHARES
Holders
Issuer 145 347 97 73 18 680
Chess 320 753 252 339 48 1712
Total 465 1100 349 412 66 2392
Units
Issuer 127025 896862 736881 1927715 10772359 14460842
Chess 259876 2037368 1968645 10255450 119104147 133625486
Total 386901 2934230 2705526 12183165 129876506 148086328
TOTAL HOLDERS FOR CLASSES SELECTED 2392
TOTAL UNITS " " " 148086328
CLASS: OPT/LIST OPT EXP 25/11/18 @ $0.27
HOLDER NO NAME AND ADDRESS UNITS % I/C RANK
ACCBELL NOMINEES PTY LTD 16,171,431 32.52 1
HSBC CUSTODY NOMINEES 8,067,228 16.22 2
(AUSTRALIA) LIMITED-GSCO ECA
HSBC CUSTODY NOMINEES 5,918,889 11.90 3
(AUSTRALIA) LIMITED
CITICORP NOMINEES PTY LIMITED 3,773,752 7.59 4
JAGEN PTY LTD 2,857,143 5.75 5
J P MORGAN NOMINEES AUSTRALIA 2,442,083 4.91 6
LIMITED
BNP PARIBAS NOMS PTY LTD 2,416,029 4.86 7
<DRP>
WARBONT NOMINEES PTY LTD 1,650,000 3.32 8
<ACCUMULATION ENTREPOT A/C>
UBS NOMINEES PTY LTD 1,250,000 2.51 9
HSBC CUSTODY NOMINEES 1,000,000 2.01 10
(AUSTRALIA) LIMITED - A/C 3
CAPITAL MACQUARIE PTY LIMITED 275,472 0.55 11
DR CHOON-JOO KHO 257,143 0.52 12
4 EYES LIMITED 234,793 0.47 13
<WORSLEY FAMILY A/C>
CAPITA TRUSTEES LIMITED 187,517 0.38 14
<MK PENSION PLAN-473278 A/C>
PHILADELPHIA INVESTMENTS 186,405 0.37 15
PTY LTD
PHILADELPHIA INVESTMENTS PTY 145,218 0.29 16
LTD
ABN AMRO CLEARING SYDNEY 143,000 0.29 17
NOMINEES PTY LTD
<CUSTODIAN A/C>
TRADERS MACQUARIE PTY LIMITED 129,595 0.26 18
M F M PROPERTIES PTY LIMITED 112,510 0.23 19
PHILADELPHIA INVESTMENTS PTY 110,509 0.22 20
LTD
*** REPORT TOTAL *** 47,328,717 95.18
*** REMAINDER *** 2,397,955 4.82
-----------------------
*** GRAND TOTAL *** 49,726,672 100.00
=======================
1 1001 5001 10001 100001 * TOTAL *
to to to to to
1000 5000 10000 100000 (MAX)
OPT /LIST OPT EXP 25/11/18 @ $0.27
Holders
Issuer 59 25 11 4 5 104
Chess 176 111 45 40 15 387
Total 235 136 56 44 20 491
Units
Issuer 29645 60467 75518 104034 847199 1116863
Chess 86545 295835 324528 1421383 46481518 48609809
Total 116190 356302 400046 1525417 47328717 49726672
TOTAL HOLDERS FOR CLASSES SELECTED 491
TOTAL UNITS " " " 49726672